Applying A Partnering Approach To Meeting Unmet Medical Need

Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable with Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy (view full video here). In this segment, Contag and Lockert discuss the why behind taking an outsourced/partnered approach to drug development, along with how to go about assessing consultancies in the process. For more information be sure to read the wisdom shared by Contag in, “A Small Biopharma’s View Of Working With CROs,” published in the July 2020 CRO Leadership Awards special supplement.